Rivaroxaban and usual care had similar rates of recurrent VTE and bleeding in symptomatic PE

ACP Journal Club21 August 2012Rivaroxaban and usual care had similar rates of recurrent VTE and bleeding in symptomatic PEDaniel M. Witt, PharmD, FCCP, BCPSDaniel M. Witt, PharmD, FCCP, BCPSKaiser Permanente Colorado, Aurora, Colorado, USA (D.M.W.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-157-4-201208210-02006 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Source CitationBüller HR, Prins MH, Lensing AW, et al; EINSTEIN-PE Investigators. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med. 2012;366:1287-97. https://pubmed.ncbi.nlm.nih.gov/22449293Clinical Impact RatingsGIM/FP/GP: Cardiology: Hematology: Pulmonology: Reference1 EINSTEIN Investigators, Bauersachs R, Berkowitz SD, et al. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010;363:2499-510. [PMID: 21128814]. Google Scholar Author, Article, and Disclosure InformationAffiliations: Kaiser Permanente Colorado, Aurora, Colorado, USA (D.M.W.)This article was published at Annals.org on 7 August 2012. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByBeinparese nach HüftendoprothesenimplantationA Review of Thrombosis and Antithrombotic Therapy in Microvascular Surgery 21 August 2012Volume 157, Issue 4Page: JC2-6KeywordsCellsHemoglobinHemorrhagePulmonary embolismPulmonary medicineResearch laboratoriesSafetyVenous thromboembolismVitamin K ePublished: 21 August 2012 Issue Published: 21 August 2012 CopyrightCopyright © 2012 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...